Abstract P125: Interaction Effects of Diabetes and Subclinical Hypothyroidism on Heart Rate Variability. The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

Circulation ◽  
2020 ◽  
Vol 141 (Suppl_1) ◽  
Author(s):  
Rosangela Hoshi ◽  
Itamar S Santos ◽  
Eduardo Dantas ◽  
Rodrigo Andreao ◽  
Bruce Duncan ◽  
...  

Background: Diabetes and subclinical hypothyroidism are frequently coexisting conditions. The separated effects of each one on the cardiovascular system and cardio autonomic function are known. However, it has not been investigated yet whether the presence of both diseases has a joint influence on the cardiac autonomic system. As the autonomic nervous system is involved in cardiovascular, endocrine, and metabolic control, the association of diabetes and subclinical hypothyroidism might have combined effects, leading to cardio autonomic impairment and rising cardiovascular risk. Aim: To analyze the interaction effects of diabetes and subclinical hypothyroidism on Heart Rate Variability parameters among adults. using the participants enrolled at the baseline data of t Methods: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) is a cohort of 15015 men and women aged 35 to 74 years-old recruited in 2008-10. Participants were categorized into four groups: non-diabetes with normal thyroid function (controls), non-diabetes with subclinical hypothyroidism; diabetes with normal thyroid function; and diabetes with subclinical hypothyroidism. Heart Rate Variability analyses were performed in time and frequency domains: Standard Deviation of NN interval (SDNN); Root of the Mean of the Sum of the Squares of Differences between adjacent NN intervals (RMSSD, Low-Frequency (LF) and High-Frequency (HF) on 5-minute time series collected in the supine position. For each Heart Rate Variability parameter, we divided the sample into quartile groups, using the fourth quartile as reference. We analyzed the associations with the highest quartile group for each Heart Rate Variability parameter using additive and multiplicative terms in logistic models. Results: Point Odds Ratio, and 95% Confidence Intervals (95%CI) estimates for the first quartiles of all Heart Rate Variability measures were higher for subjects with the combination of both, “diabetes plus subclinical hypothyroidism” than for people with only the diagnosis of diabetes: SDNN: 2.61 (95%CI = 1.13 to 6.05) vs. 1.52 (95%CI =1.25 to 1.85); RMSSD: 2.70 (95%CI =1.18 to 6.18) vs. 1.48 (95%CI =1.21 to 1.80); LF: 2.82 (95%CI =1.05 to 7.56) vs. 1.73 (95%CI =1.40 to 2.13); HF: 3.07 (95%CI =1.21 to 7.75) vs. 1.41 (95%CI =1.16 to 1.71). Nonetheless, no significant multiplicative interaction terms between diabetes and subclinical hypothyroidism were found for the association with HRV variables. Conclusion: There is a potential joint impact on Heart Rate Variability showed by additive effects between diabetes and subclinical hypothyroidism.

2019 ◽  
Vol 35 (7) ◽  
Author(s):  
Rosangela A. Hoshi ◽  
Itamar S. Santos ◽  
Eduardo M. Dantas ◽  
Rodrigo V. Andreão ◽  
Maria Inês Schmidt ◽  
...  

Nutrients ◽  
2017 ◽  
Vol 9 (7) ◽  
pp. 741 ◽  
Author(s):  
Rackel de Oliveira ◽  
Larissa Araújo ◽  
Roberta de Figueiredo ◽  
Alessandra Goulart ◽  
Maria Schmidt ◽  
...  

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A830-A831
Author(s):  
Dorina Minxuri ◽  
Anila Mitre ◽  
Silva Bino ◽  
Ina Toska ◽  
Ina Mulla

Abstract Introduction: Albania is classified as iodine deficient region and endemic goiter in this country has been a concern for public health. A salt iodization program has been implemented in Albania since 2008. Most of regions still remain with a mild or moderate iodine deficiency there are no studies on prevalence of thyroid autoimmune disorders. The purpose of this study was to assess thyroid function and the presence of thyroid antibodies in subjects that were not previously diagnosed or treated for thyroid disorders. Methods: This is a cross-sectional study performed in a cohort of patients in Albania during a 2 year period (january 2018-january 2020). We assessed the prevalence of thyroid function disorders and presence of thyroid antibodies in 5047 subjects (81% females and 19% males). Individuals previously diagnosed or treated for thyroid disease were excluded from the study. TSH, Free T4, total T3, Anti TPO(thyroid peroxidase) and anti TG (thyroglobulin) were measured with electrochemiluminescence method with Cobas 6000 Roche Diagnostics. We calculated the frequency of thyroid antibodies and the abnormal thyroid function. Statistical analysis was performed to see if there was a difference between individuals with positive antibodies and those negative for antibodies. Results: 91 % (4596) of subjects resulted euthyroid. We found a low prevalence of overt thyroid dysfunction (hyperthyroidism 0.48% and hypothyroidism 1.69%). The rates of subclinical hypothyroidism and hyperthyroidism were 5.5% and 1.4% respectively. The prevalence of positive thyroid antibodies, at least one of them was 28% in females and 14% in males (2:1 ratio). 97.3 % of subjects who testet negative for antibodies had normal thyroid function compared to 73.5% in antibodies positive group. There was a significant difference for subclinical hypothyroidism and other thyroid disorders between antibodies positive group and antibodies negative group (p value <0.0000119% of individuals(from 5047 examined) had normal thyroid function and resulted positive for anti TPO or anti TG. Conclusions: Undiagnosed biochemical thyroid dysfunctions were common in subjects living in a mild to moderate iodine-deficient area especially subclinical hypothyroidism. TSH level correlated well with the presence of antibodies resulting in significant difference in thyroid function between 2 groups. We found a high prevalence (19%) of thyroid antibodies in euthyroid subjects. TPO antibodies in euthyroid subjects can be used to identify subjects with increased risk for hypothyroidism such as women who are pregnant (to predict first trimester or postpartum thyroid dysfunction), patients with other autoimmune diseases, subjects on drugs like amiodarone or relatives of patients with autoimmune thyroid diseases.


2018 ◽  
Vol 55 (6) ◽  
pp. e13052 ◽  
Author(s):  
Eduardo Miranda Dantas ◽  
Andrew Haddon Kemp ◽  
Rodrigo Varejão Andreão ◽  
Valdo José Dias da Silva ◽  
André Russowsky Brunoni ◽  
...  

2002 ◽  
Vol 41 (06) ◽  
pp. 245-251 ◽  
Author(s):  
M. Knietsch ◽  
T. Spillmann ◽  
E.-G. Grünbaum ◽  
R. Bauer ◽  
M. Puille

SummaryAim: Establishment of radioiodine treatment of feline hyperthyroidism in veterinary routine in accordance with German radiation protection regulations. Patients and methods: 35 cats with proven hyperthyroidism were treated with 131I in a special ward. Thyroid uptake and effective halflife were determined using gammacamera dosimetry. Patients were released when measured whole body activity was below the limit defined in the German “Strahlenschutzverordnung”. Results: 17/20 cats treated with 150 MBq radioiodine and 15/15 cats treated with 250 MBq had normal thyroid function after therapy, normal values for FT3 and FT4 were reached after two and normal TSH levels after three weeks. In 14 cats normal thyroid function was confirmed by controls 3-6 months later. Thyroidal iodine uptake was 24 ± 10%, effective halflife 2.5 ± 0.7 days. Whole body activity <1 MBq was reached 13 ± 4 days after application of 131I. Radiation exposure of cat owners was estimated as 1.97 Sv/MBq for adults. Conclusion: Radioiodine therapy of feline hyper-thyroidism is highly effective and safe. It can easily be performed in accordance with German radiation protection regulations, although this requires hospitalisation for approximately two weeks. Practical considerations on radiation exposure of cat owners do not justify this long interval. Regulations for the veterinary use of radioactive substances similar to existing regulations for medical use in humans are higly desirable.


Sign in / Sign up

Export Citation Format

Share Document